FMR LLC's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Feb 15, 2024
- Accession no.
- 0001209191-24-003394
- Filed
- Feb 15, 2024
- Trade date
- Feb 13-14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $27.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| FMR LLCCIK 0000315066 | Other: See Remark 1 |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Common Stock | SSaleDisposed | −410 | $30.28 | −$12,414.8 | 2,773,068 | Indirect | |
| Feb 13, 2024 | Common Stock | SSaleDisposed | −1,155 | $30.93 | −$35,724.15 | 2,771,913 | Indirect | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −854,323 | $30.51 | −$26,065,394.73 | 1,281,188 | Indirect | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −45,677 | $31.34 | −$1,431,517.18 | 1,235,511 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.